Related Experiment Video
Updated: Mar 31, 2026

09:38
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
9.3K
Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma
Kieron Dunleavy1, Stefania Pittaluga2, Margaret Shovlin3
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA dunleavk@mail.nih.gov.
Haematologica
|November 1, 2015
Abstract
No abstract available in PubMed .

